PRALATREXATE for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 68 adverse event reports in the FDA FAERS database where PRALATREXATE was used for Product used for unknown indication.
Most Reported Side Effects for PRALATREXATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 107 | 23.0% | 37 | 12 |
| Stomatitis | 93 | 20.0% | 30 | 33 |
| Platelet count decreased | 56 | 12.0% | 15 | 21 |
| Disease progression | 46 | 9.9% | 21 | 11 |
| Neutrophil count decreased | 40 | 8.6% | 13 | 16 |
| Anaemia | 39 | 8.4% | 7 | 21 |
| Pyrexia | 38 | 8.2% | 4 | 20 |
| Mucosal inflammation | 37 | 7.9% | 8 | 18 |
| Drug ineffective | 32 | 6.9% | 9 | 8 |
| Off label use | 30 | 6.4% | 6 | 10 |
| Death | 26 | 5.6% | 26 | 8 |
| Febrile neutropenia | 26 | 5.6% | 7 | 16 |
| Neutropenia | 24 | 5.2% | 6 | 13 |
| Thrombocytopenia | 23 | 4.9% | 6 | 10 |
| Therapeutic response decreased | 22 | 4.7% | 3 | 5 |
Other Indications for PRALATREXATE
Peripheral t-cell lymphoma unspecified (157)
Cutaneous t-cell lymphoma (36)
Angioimmunoblastic t-cell lymphoma (24)
T-cell lymphoma (21)
Mycosis fungoides (17)
Angioimmunoblastic t-cell lymphoma stage iii (14)
Anaplastic large-cell lymphoma (13)
Peripheral t-cell lymphoma unspecified stage iv (13)
Angioimmunoblastic t-cell lymphoma stage iv (12)
Hepatosplenic t-cell lymphoma (12)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)